Pharmaceuticals (84) | Separation Agreements (84)

Browse by Company

4Front Ventures Corp. (1)
Acreage Holdings, Inc. (1)
Amag Pharmaceuticals (2)
Amneal Pharmaceuticals, Inc. (6)
Amphastar Pharma (1)
Ampio Pharmaceuticals, Inc. (1)
ANI Pharma Inc (1)
Aquestive Therapeutics, Inc. (1)
Baudax Bio, Inc. (1)
BIODELIVERY SCIENCES INTERNATIONAL INC (1)
Cerecor Inc. (2)
Clearside Biomedical, Inc. (2)
Cure Pharmaceutical Holding Corp. (1)
Eloxx Pharmaceuticals, Inc. (1)
Endo International plc (1)
Evolus, Inc. (1)
Exactus, Inc. (1)
HARVEST HEALTH & RECREATION INC. (1)
Horizon Pharma plc (1)
IMARA Inc. (1)
INNOVATE BIOPHARMACEUTICALS, INC. (4)
Kaleido Biosciences, Inc. (1)
Lannett Company, Inc. (1)
Level Brands, Inc. (1)
Lyra Therapeutics, Inc. (1)
Mallinckrodt (1)
Merck (1)
MJ Holdings, Inc. (1)
Mylan N.V. (6)
MYnd Analytics, Inc. (2)
NEKTAR THERAPEUTICS (1)
Novan, Inc. (2)
OCULAR THERAPEUTIX, INC (3)
Onconova Therapeutics, Inc. (1)
Pfizer (5)
Recro Pharma, Inc. (2)
RELMADA THERAPEUTICS, INC. (1)
Revance Therapeutics, Inc. (2)
scPharmaceuticals Inc. (1)
SenesTech, Inc. (2)
Sonoma Pharmaceuticals, Inc. (2)
Teligent, Inc. (1)
Terra Tech Corp. (3)
TETRAPHASE PHARMACEUTICALS INC (1)
TEVA PHARMACEUTICAL INDUSTRIES LTD (1)
Textmunication Holdings, Inc. (2)
The Medicines Company (1)
Tilray, Inc. (4)
Vitality Biopharma, Inc. (1)
Zomedica Pharmaceuticals Corp. (1)

Recent Contracts

Agreement to Amend Separation Agreement. Vedadi February 9, 2021 (HARVEST HEALTH & RECREATION INC., Filed With SEC on May 13, 2021)
Separation Agreement and Complete Release dated as of April 29, 2021, by and between Jon Levin and Tilray, Inc (Tilray, Inc., Filed With SEC on May 4, 2021)
Separation Agreement and Complete Release dated as of April 30, 2021, by and between Michael Kruteck and Tilray, Inc (Tilray, Inc., Filed With SEC on May 4, 2021)
Separation Agreement between Terra Tech Corp. and Steven J. Ross, dated April 13, 2021 (Terra Tech Corp., Filed With SEC on April 14, 2021)
Separation Agreement and Release with Joshua N. Rosen dated January 2, 2021 (4Front Ventures Corp., Filed With SEC on April 7, 2021)
Separation Agreement and General Release, dated as of April 1, 2021, by and between Gregory C. Williams and Eloxx Pharmaceuticals, Inc (Eloxx Pharmaceuticals, Inc., Filed With SEC on April 1, 2021)
Separation Agreement, dated as of December 16, 2020, by and between Aquestive Therapeutics, Inc. and John T. Maxwell (Aquestive Therapeutics, Inc., Filed With SEC on March 9, 2021)
Separation Agreement and General Release between Endo and Terrance J. Coughlin, dated November 19, 2020 (Endo International plc, Filed With SEC on February 26, 2021)
Amendment No. 4 to the Separation and Distribution Agreement, dated as of November 15, 2020, by and between us and Upjohn Inc. (Pursuant to Item 601(b)(2) of Regulation S-K, the... (Pfizer, Filed With SEC on February 25, 2021)
Transition and Separation Agreement dated February 11, 2021 between ANI Pharmaceuticals, Inc. and Robert Schrepfer (ANI Pharma Inc, Filed With SEC on February 17, 2021)